文献速递甲状腺疾病

晚期甲状腺癌治疗期间不良事件的管理

Management of Adverse Events During Treatment for Advanced Thyroid Cancer.
PubMed 文献 · Thyroid · 2025-05-22

本叙述性综述回顾已发表文献,总结晚期甲状腺癌治疗相关不良事件的发生率及管理方法。多激酶抑制剂和基因特异性抑制剂常见疲乏、高血压、胃肠道毒性、皮疹和手足综合征,部分药物发热综合征频发、血栓栓塞事件和心脏损害严重,临床试验数据、真实世界数据、专家指南和有经验临床医生的见解可指导管理。

要点

  • 晚期甲状腺癌多种治疗常见不良事件包括疲乏、高血压、胃肠道毒性、皮疹和手足综合征。
  • 发热综合征在特定药物中频发,血栓栓塞事件和心脏损害因严重性而需关注。
  • 临床试验数据、真实世界数据、专家指南和有经验临床医生的见解可指导不良事件管理。

核心结论

  • 晚期甲状腺癌治疗的毒性特征已明确,许多常见不良事件有循证管理方法。
  • 遵循这些方法优化治疗相关不良事件的管理可改善甲状腺癌患者的生活质量和结局。

研究设计与样本

  • 叙述性综述,回顾已发表文献,总结晚期甲状腺癌治疗相关不良事件的发生率和管理方法。

主要发现

  • 晚期甲状腺癌多种治疗常见不良事件包括疲乏、高血压、胃肠道毒性、皮疹和手足综合征。
  • 发热综合征在特定药物中频发,血栓栓塞事件和心脏损害因严重性而需关注。

临床怎么用

  • 临床试验数据、真实世界数据、专家指南和有经验临床医生的见解可指导许多不良事件的管理方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The management of advanced thyroid cancer has rapidly evolved as several multikinase, and gene-specific inhibitors have substantially improved survival for patients with most types of thyroid cancer. Optimizing management of the treatment-related adverse events (TRAEs) from these medications is important to improve quality of life and outcomes for patients with thyroid cancer. This narrative review discusses common and clinically significant TRAEs of treatments for thyroid cancer and effective management approaches. Summary: Published literature was reviewed to summarize available information on the incidence of TRAEs with medications used to treat thyroid cancer and management approaches for these TRAEs. There are common TRAEs across many treatments for advanced thyroid cancer including fatigue, hypertension, gastrointestinal toxicities, rashes, and hand-foot syndrome. Additionally, several other TRAEs with thyroid cancer treatments are significant because of their frequency with specific medications (e.g., pyrexia syndrome) or their severity (e.g., thromboembolic events and cardiac impairment). Data from clinical trials and real-world data along with expert guidelines and insights from experienced clinicians can guide management approaches for many of these TRAEs. Conclusions: The toxicity profiles are well established for treatments for advanced thyroid cancer, there are evidence-based management approaches for many commonly encountered scenarios. Following these approaches to optimizing management of TRAEs can improve the quality of life and outcomes for patients with thyroid cancer.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Roberts TJ, Wirth LJ. Management of Adverse Events During Treatment for Advanced Thyroid Cancer. Thyroid. 2025. PMID: 40401445. doi:10.1089/thy.2024.0755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。